Enterprise Value
86.98M
Cash
60.62M
Avg Qtr Burn
-7.856M
Short % of Float
19.98%
Insider Ownership
4.37%
Institutional Own.
25.12%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
PDS01ADC + Radiation Therapy Details Prostate cancer | Phase 2 Data readout | |
PDS01ADC + ICI Details Human papillomavirus | Phase 2 Data readout | |
PDS0101 + Chemo Details Cancer, Cervical cancer | Phase 2 Data readout | |
PDS0101 + Keytruda Details Cancer, Head and neck squamous cell carcinoma | Phase 2 Data readout | |
PDS0101 + Keytruda Details Solid tumor/s, Cancer, HPV+ oropharyngeal cancer | Phase 2 Data readout | |
PDS01ADC + Histone Deacetylase (HDAC) inhibitor Details Cancer, Bladder cancer | Phase 1/2 Data readout | |
PDS0301 + Docetaxel Details Cancer, Prostate cancer | Phase 1/2 Data readout | |
PDS01ADC + Docetaxel Details Prostate cancer | Phase 1/2 Data readout | |
PDS01ADC Details Kaposi Sarcoma | Phase 1/2 Data readout |